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NLRP10 is a nucleotide-binding oligomerization domain-like receptor that functions as 
an intracellular pattern recognition receptor for microbial products. Here, we generated 
a Nlrp10−/− mouse to delineate the role of NLRP10 in the host immune response and 
found that Nlrp10−/− dendritic cells (DCs) elicited sub-optimal IFNγ production by antigen- 
specific CD4+ T cells compared to wild-type (WT) DCs. In response to T-cell encounter, 
CD40 ligation or Toll-like receptor 9 stimulation, Nlrp10−/− DCs produced low levels of 
IL-12, due to a substantial decrease in NF-κB activation. Defective IL-12 production was 
also evident in vivo and affected IFNγ production by CD4+ T cells. Upon Mycobacterium 
tuberculosis (Mtb) infection, Nlrp10−/− mice displayed diminished T helper 1-cell 
responses and increased bacterial growth compared to WT mice. These data indicate 
that NLRP10-mediated IL-12 production by DCs is critical for IFNγ induction in T cells 
and contributes to promote the host defense against Mtb.
Keywords: nlrP10, dendritic cells, cpg Dna, toll-like receptor 9, il-12, T helper 1, iFnγ, Mycobacterium tuberculosis
inTrODUcTiOn
Dendritic cells (DCs) sense infectious agents through germline-encoded pattern recognition recep-
tors (PRRs) that recognize the molecular patterns expressed by micro-organisms and endogenous 
stimuli. PRR activation induces signaling cascades that initiate an inflammatory response elicited in 
part, by cytokine production. The membrane-bound and endosomal Toll-like receptors (TLRs) are 
PRRs that have been most extensively investigated (1), but recent research has discovered families of 
cytosolic PRRs, including nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) 
(2). Some of these sensors can form an inflammasome that regulates the activation of caspase-1 to 
drive IL-1β and IL-18 cytokine processing and release (3). The best-characterized inflammasome 
complex comprises the inflammasome sensor NLRP3, the adaptor ASC and the caspase-1 precur-
sor. This inflammasome can be activated by environmental stimuli and a plethora of chemically 
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and structurally different stimuli, including pathogen-associated 
molecular patterns (PAMPs) and danger-associated molecular 
patterns that are released during cellular damage [reviewed in 
Ref. (4)].
NLRP proteins are involved in pathogen recognition and 
inflammatory and immune responses to microbial infections. 
NLRP6 contributes to intestinal homeostasis by preventing 
pathogenic colitis associated with microbial dysbiosis and 
regulates intestinal mucosa tissue repair (5). NLRP12 has been 
linked to Yersinia pestis infection recognition (6), and exhibits 
an inflammasome-independent anti-inflammatory function that 
protects mice from experimental colitis by inhibiting the canoni-
cal and non-canonical NF-κB pathways (7). Despite such research 
efforts our knowledge as to how NLRs modulate the immune 
response is limited and many NLRs remain poorly characterized.
NLRP10 is an NLR that lacks the characteristic C-terminal 
leucine-rich (LRR) domain present in most members of this 
protein family (8). Over-expression studies in mice showed that 
human NLRP10 negatively regulated NF-κB and cell death and 
inhibited IL-1β release in vivo and in vitro (9). These NLRP10 
knock-in mice showed resistance to lipopolysaccharide (LPS)-
induced endotoxic shock, likely due to decreased inflammatory 
cytokine release (9). Furthermore, peritoneal macrophages 
from these mice released low levels of IL-1β in response to 
Salmonella enterica serovar Typhimurium infection or TLR7 
stimulation (9). Despite such support for a role of NLRP10 in 
IL-1β processing and release, other studies have not provided 
evidence that NLRP10 contributes to inflammasome activa-
tion (10, 11). Consequently, an inflammasome-independent 
function of NLRP10 has been suggested, based on interactions 
between NLRP10, NOD1, and its signaling partners RIPK2, 
TAK1, and NEMO in human epithelial cells (12). More 
recently, NLRP10 has been implicated in immune response to 
Leishmania major (13).
A role for NLRP10 in adaptive immunity has also been 
proposed. A recent study showed significantly reduced inflam-
mation and T-cell number in the dermis of Nlrp10−/− mice 
compared to wild-type (WT) controls during irritant-induced 
contact hypersensitivity (14). Others have suggested that 
Nlrp10−/− mice display an impaired T-cell immune response 
due to the inability of Nlrp10−/− DCs to transport antigens to 
draining lymph nodes (10, 11). However, the Nlrp10−/− mice 
used in these early studies carried an unintended mutation in 
Dock8, which was later found to be the primary cause of defec-
tive DC migration (15, 16). These reports do, however, highlight 
the need to further investigate the role of NLRP10 in adaptive 
immunity.
Here, we generated a novel Nlrp10−/− mouse line to investigate 
whether NLRP10 contributes to eliciting CD4+ T-cell-mediated 
immune response. We found that Nlrp10−/− DCs were defective 
in IL-12 production both in vitro and in vivo and had defective 
NF-κB signaling. Sub-optimal IL-12 synthesis impaired the pro-
duction of IFNγ by antigen-specific CD4+ T cells, which dimin-
ished the ability of Nlrp10−/− mice to respond to Mycobacterium 
tuberculosis (Mtb) infection. These data suggest that NLRP10 is 
central to DC-mediated type 1 helper T (Th1)-cell-dependent 
immunity to intracellular bacteria.
MaTerials anD MeThODs
Mice
The Nlrp10−/− mouse was generated by genome editing using 
CompoZr™ Zinc-Finger Nuclease technology (Sigma-Aldrich) 
(17–19). C57BL/6J mice were purchased from the Biological 
Resource Centre (BRC; A*STAR, Singapore). B6.129S7-Rag1tm1Mo
mTg(TcraTcrb)425Cbn mice (OT-II-Rag1−/−, abbreviated to OT-II 
thereafter) were obtained from Taconic. All mice were maintained 
on a B6 background under specific pathogen-free conditions. For 
Mtb infection experiments, mice were housed in a Biosafety level 
3 laboratory and treated humanely. All experimental procedures 
were approved by the Institutional Biosafety Committee (IBC) 
and Institutional Animal Care and Use Committee (IACUC) 
of the BRC (A*STAR) in compliance with their Guidelines for 
Animal Experiments.
cell Differentiation and stimulation
Bone marrow (BM) cells were harvested from femurs and tibias 
of WT and Nlrp10−/− mice and cultured in Iscove’s Modified 
Dulbecco’s Medium (IMDM) with 10% fetal bovine serum 
(Hyclone), 1% penicillin/streptomycin, and 10% conditioned 
medium containing granulocyte-macrophage colony-stimulating 
factor for 7–8  days to generate DCs. Purity of the culture was 
assessed by flow cytometry, measuring the co-expression of 
CD11c and MHC-II. A total of 1  ×  105 DCs/well were plated 
in a 96-well plate and stimulated for 1, 2, and 3  days with the 
following TLR agonists: Pam(3)CSK(4) (1 µg/ml), LPS-B4 from 
E. coli (0.1 µg/ml), CpG DNA type B (0.001–10 µM), or PolyI:C 
(100 µg/ml), from InvivoGen. For CD40 stimulation, DCs were 
stimulated with MegaCD40L (50  ng/ml; Adipogen) for 8, 24, 
48, and 72 h or with L929 cells expressing murine CD40 ligand 
(CD40L) at a DC:L929 ratio of 1:4 for 24 h.
T-cell Proliferation assays
Lymph nodes and spleens of OT-II mice were harvested and 
processed to a single-cell suspension. Red blood cells (RBCs) 
were lysed in AKT buffer (0.83% NH4Cl, 0.1% KHCO3, 0.37 g 
EDTA), and the remaining cells were washed twice in PBS. 
CD4+ T  cells were purified by magnetic bead immunoselec-
tion (Miltenyi Biotec) and labeled with CellTrace Violet (Life 
Technologies) in PBS for 15 min at 37°C before three washes 
with PBS. For in  vitro experiments, DCs were incubated 
overnight with EndoGrade endotoxin-free ovalbumin (OVA) 
(20 µg/ml; Hyglos), then washed and plated in a 96-well plate 
at 5 × 104/well with labeled OT-II CD4+ T cells (1 × 105/well). 
After 3  days, cells were collected, washed, and labeled with 
anti-CD3, anti-CD4, anti-CD45.1, and anti-TCR Vβ5.1/5.2 
antibodies (BD Bioscience). For in vivo experiments, CellTrace 
Violet-labeled OT-II CD4+ T  cells were injected via the 
retro-orbital plexus vein into WT and Nlrp10−/− mice. After 
24 h, mice were immunized by i.p. injection with EndoGrade 
endotoxin-free OVA protein (25 μg/mouse; Hyglos) mixed with 
1 mg Imject Alum Adjuvant (Thermo Scientific) in 500 µl PBS. 
T-cell proliferation was measured by dye dilution 3 days later. 
Data were analyzed using FlowJo (TreeStar Inc.). The Division 
3
Vacca et al. NLRP10 Enhances the Th1 Immune Response
Frontiers in Immunology | www.frontiersin.org November 2017 | Volume 8 | Article 1462
Index represents the average number of cell divisions of a cell in 
the original population, including the peak of undivided cells.
Dc and T-cell co-culture
Bone marrow-derived DCs (BMDCs) or conventional splenic 
CD11c+ MHC-IIhigh DCs were incubated overnight in EndoGrade 
endotoxin-free OVA (Hyglos) at the indicated concentrations. 
DCs were then washed, re-suspended in complete IMDM and 
replated at different quantities (1.25, 2.5, 5.0, or 10  ×  104) in 
96-well plates in quadruplicates. Naive OVA-specific CD4+ T cells 
(1 × 105/well) isolated from OT-II mouse spleens were added to 
each well. After 3 days, culture supernatants were harvested and 
analyzed for IFNγ by ELISA.
antigen Processing assay
Bone marrow-derived DCs were pulsed for 1 h with 50 µg recom-
binant Eα-RFP (20). Cells were then washed in PBS and chased 
for the indicated time points. DCs were stained with the Y-Ae 
antibody [clone eBioY-Ae (YAe, Y-Ae); eBioscience] recognizing 
the Eα peptide 52-68 loaded on I-Ab MHC-II molecules and 
analyzed by flow cytometry.
Bacterial strains and growth conditions
Mycobacterium tuberculosis H37Rv was grown in Middlebrook 
7H9 broth (BBL Microbiology Systems, USA) supplemented 
with Albumin Dextrose Catalase (Difco laboratories, USA) and 
0.05% Tween 80 at 37°C for 5–7  days to an optical density of 
0.4–0.5 (OD600). Mycobacterial cells were pelleted, re-suspended 
in fresh 7H9 broth with 20% glycerol and stored at −80°C. On 
the day of infection, the cells were thawed, washed, and sonicated 
before use.
Mtb Murine infection and enumeration of 
Mtb colony-Forming Unit (cFU)
Wild-type and Nlrp10−/− mice were infected with Mtb H37Rv 
using a nose-only aerosolization exposure system (CH Tech-
nologies, USA) as previously described (21). Mice (n = 3–4) were 
sacrificed on day 1 to determine the number of bacteria implanted 
in the lungs, or euthanized at pre-determined time points post-
infection and the lungs were aseptically excised, washed in PBS 
and homogenized in PBS containing 0.25% Tween 80 using a 
MACS tissue dissociator (Miltenyi Biotech). The mycobacterial 
load in the lung tissue was quantified by plating dilutions of tissue 
homogenates on Middlebrook 7H11 agar plates supplemented 
with Oleic Albumin Dextrose Catalase (Sigma-Aldrich), in 
triplicate. Agar plates were incubated at 37°C for 2  weeks and 
visible colonies were counted. The CFU obtained from two or 
three dilutions was used to calculate the total number of CFUs 
per lung per mouse. The infection experiments were performed 
five times.
isolation and Ex Vivo stimulation  
of lung cells from Mtb-infected Mice
On day 35 post-infection, mice were euthanized and the lungs 
were aseptically removed and gently homogenized in PBS using 
a MACS tissue dissociator. Lung cells were passed through a 
40 µm cell strainer (BD Biosciences). RBCs were lysed in RBC 
lysis buffer (Lonza), washed and re-suspended in RPMI-1640 
medium and the cells were counted. Mouse BMDCs (5 × 106) 
from WT and Nlrp10−/− mice were infected with Mtb (MOI 1). 
After 4 h, freshly isolated mouse lung cells (0.5 × 106) from Mtb-
infected Nlrp10−/− and WT mice were added and cultured for 
16 h. Brefeldin A (1 µg/ml) and Monensin (1 µM) were added for 
the final 4 h of culture. The cells were then washed and stained 
with PE-Cy7-anti-CD3 (Biolegend #100220), Pacific-blue-
anti-CD4 (Biolegend #100428), and LIVE/DEAD fixable green 
dead cell stain (Invitrogen #L23101). Cells were washed, fixed, 
and permeabilized using Cytofix/Cytoperm buffer (Cytofix/
Cytoperm kit; BD Pharmingen), washed twice with Perm/
wash buffer, and then stained with intracellular APC-anti-IFNγ 
(Biolegend #505810). Stained cells were fixed and analyzed using 
a BD LSR Fortessa™ (BD Biosciences). Data analysis was carried 
out using FlowJo.
cpg Dna Treatment In Vivo
Mice were exposed to CpG DNA (ODN1826, class B, 50  μg/
mouse, InvivoGen) by i.p. injection and plasma samples and 
spleens were collected 3  h later. Plasma was separated from 
the blood and cytokine levels were measured by ELISA. Total 
RNA was isolated from sorted splenic DCs and converted to 
cDNA by reverse transcription (Experimental Procedures in 
Supplementary Material).
To assess IFNγ production in vivo, OT-II CD4+ T cells were 
adoptively transferred to WT and Nlrp10−/− mice followed by 
i.p. injection of OVA (20  μg/mouse) and CpG DNA (20  μg/
mouse) the following day. Spleens were harvested after 3 days 
and total splenocytes were co-cultured with WT and Nlrp10−/− 
BMDCs loaded or not with OVA. Cell-culture supernatants 
were collected after 3 days and assessed for IFNγ production 
by ELISA.
Measurement of cytokines
Mouse IL-12p40, IL-12p70, IL-6, IFNγ, and TNFα levels were 
measured using the Duoset ELISA kits (R&D Systems) according 
to the manufacturer’s instructions.
statistical analysis
Data represent the mean  ±  SD or SE, as indicated. Data are 
derived from a minimum of three independent experiments 
unless stated otherwise. Statistical significance was determined 
by one-way ANOVA followed by Bonferroni post hoc test using 
GraphPad Prism 7 (GraphPad). A p < 0.05 was considered sta-
tistically significant.
resUlTs
characterization of Nlrp10−/− Mice
Nlrp10−/− mice were generated by CompoZr™ Zinc-Finger 
Nuclease technology (18) (Figures S1A–D in Supplementary 
Material) and mRNA expression analysis confirmed complete 
ablation of Nlrp10 in the spleen and heart (Figure S1E in 
Supplementary Material). As a previous Nlrp10−/− mouse model 
FigUre 1 | DC-mediated Nlrp10 expression triggers IFNγ production by antigen-specific T cells. (a–c) IFNγ released by OT-II T cells co-cultured with immature 
(a,B) or mature (c) WT or Nlrp10−/− DCs loaded with increasing OVA concentrations (1.62–25 µg/ml) (a) and at different DC:OT-II T-cell ratios (B,c) measured in 
culture supernatants after 3 days by ELISA. Data presented are from single experiments and are representative of three independent experiments. (D) Expression of 
T-cell activation markers 3 days after incubation with OVA-loaded WT or Nlrp10−/− DCs. (e) IFNγ production by OT-II T cells co-cultured for 3 days with different 
amounts of splenic DCs isolated from WT or Nlrp10−/− mice and loaded overnight with OVA antigen (25 µg/ml). Data are expressed as the means ± SD. *p < 0.05; 
**p < 0.01; ***p < 0.001. Abbreviations: DC, dendritic cells; WT, wild-type; MFI, median fluorescence intensity; OVA, ovalbumin.
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(10) carried an unintended mutation in Dock8 (15, 16), we 
specifically checked Dock8 expression in our Nlrp10−/− mice and 
found normal expression levels (Figure S1F in Supplementary 
Material). Our Nlrp10−/− mice were viable and fertile, devel-
oped a normal immune system composition (Figure S1G in 
Supplementary Material) and had a normal immune-cell profile 
in the spleen and lymph nodes when housed in a pathogen-free 
environment (Figure S1H in Supplementary Material).
The nlrP3 inflammasome can Be 
activated independently of nlrP10
NLRP10 was suggested to negatively regulate the NLRP3 
inflammasome activation in a glial cells line (22), but later stud-
ies using macrophages from Nlrp10−/− mice (carrying a Dock8 
deletion) (10, 15, 16) did not support these findings. Here, 
we used our Nlrp10−/− mice to examine the role of NLRP10 
in inflammasome-mediated IL-1β release. LPS-primed, 
BM-derived Nlrp10−/− DCs produced normal levels of IL-1β in 
response to NLRP3 inflammasome activators, indicating that 
NLRP10 deficiency does not impact on NLRP3 inflammasome 
activation in  vitro (Figure S2A in Supplementary Material). 
Moreover, monosodium urate-induced inflammation in 
Nlrp10−/− mice seemed normal, as evidenced by neutrophil and 
inflammatory monocyte recruitment to the peritoneal cavity 
(Figure S2B in Supplementary Material). These results indicate 
that NLRP10 is not involved in NLRP3 inflammasome activa-
tion or IL-1β production in vitro or in vivo.
absence of nlrP10 in Dcs impairs 
antigen-specific secretion of iFnγ by 
cD4+ T cells
As DCs are central initiators of the T-cell response, we assessed 
Nlrp10 expression in conventional splenic CD8a+ DCs, which 
could be induced upon CpG DNA stimulation (Figures S3A,B 
in Supplementary Material), suggesting a role for Nlrp10 in 
DC function. To further interrogate this finding, we used 
OVA-specific OT-II T  cells derived from OT-II/Rag1−/− mice. 
Nlrp10−/− DCs elicited a low CD4+ T-cell activation, as inferred 
by IFNγ production, in a dose response manner to OVA 
(Figure 1A) and at all DC:OT-II T-cell ratios tested (Figure 1B). 
The inability of Nlrp10−/− DCs to trigger an OVA-specific CD4+ 
T-cell response was independent of the maturation stage of the 
DCs, as antigen-activated OT-II CD4+ T cells stimulated with 
LPS-matured Nlrp10−/− DCs released lower levels of IFNγ com-
pared to T cells cultured with matured WT DCs (Figure 1C). 
Additionally, OT-II CD4+ T cells co-cultured with OVA-pulsed 
Nlrp10−/− DCs expressed lower amounts of T-cell activation 
markers, including CD44, CD137/4-1BB, and CD134/OX40, 
compared to OT-II CD4+ T  cells co-cultured with WT DCs 
(Figure  1D). A similar defect in DC-mediated IFNγ produc-
tion from OT-II CD4+ T cells was observed in Nlrp10−/− splenic 
DCs (Figure 1E), indicating that this effect is not restricted to 
in vitro BMDCs but extends to ex vivo isolated primary DCs. 
Collectively, these findings indicate that DC NLRP10 expres-
sion contributes to CD4+ T-cell activation.
FigUre 2 | Nlrp10−/− dendritic cells (DCs) show normal antigen uptake, processing and presentation, and T-cell stimulatory activity. (a) Cell-surface expression of 
MHC-II and co-stimulatory markers CD80, CD86, and CD40 in WT and Nlrp10−/− DCs were analyzed at steady state and after LPS treatment by flow cytometry. 
Each column represents the mean ± SD of three independent experiments. (B) WT and Nlrp10−/− DCs were loaded with Eα protein (50 µg) for 1 h; cell-surface 
presentation of Eα peptide (52–68) expressed as a percentage and MFI was assessed at the indicated time points by flow cytometry. (c) Proliferation of CellTrace 
Violet-labeled OT-II CD4+ T cells co-cultured with WT or Nlrp10−/− DCs loaded with OVA (20 µg/ml) assessed by CellTrace Violet dilution by flow cytometry. (D) 
Proliferation of CellTrace Violet-labeled OT-II CD4+ T cells that were adoptively transferred into WT or Nlrp10−/− mice immunized with OVA (25 μg/mouse) in Alum 
adjuvant. Proliferation was measured 3 days after immunization. Graphical representation of the CellTrace Violet dilution and consolidated division indices for inguinal 
lymph nodes are shown. Data are expressed as the means ± SD. n = 4 WT and n = 5 Nlrp10−/− mice per group. *p < 0.05; ns, not significant. Abbreviations: Alum, 
aluminum hydroxide; LN, lymph node; LPS, lipopolysaccharide; MFI, median fluorescence intensity; OVA, ovalbumin; WT, wild-type.
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Nlrp10−/− Dcs exhibit normal antigen 
Uptake, Processing, and Presentation  
and elicit cD4+ T-cell Proliferation
We next sought to determine the mechanisms underlying 
the sub-optimal antigen-specific T-cell response elicited by 
Nlrp10−/− DCs. We first assessed whether Nlrp10 deficiency 
resulted in aberrant expression of antigen-presenting MHC-II 
or co-stimulatory molecules on DCs. We noticed that the steady 
state, LPS-induced or CpG-induced expression of MHC-II, 
CD80, CD86, and CD40 was equivalent between Nlrp10−/− and 
WT DCs (Figure  2A; Figure S4 in Supplementary Material). 
Next, we determined whether NLRP10 influences the presenta-
tion of cognate peptides to naive antigen-specific CD4+ T cells. 
WT and Nlrp10−/− DCs were pulsed with the Eα protein for 
1 h, and the presence of processed Eα peptide 52-68 bound to 
I-Ab MHC-II molecules was assessed at different time points. 
Total Eα peptide and the percentage of DCs positive for the 
Eα were similar between WT and Nlrp10−/− DCs (Figure 2B), 
suggesting that NLRP10 is dispensable for antigen processing 
and presentation. We then examined the uptake of florescent 
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OVA by Nlrp10−/− DCs and their migration to the draining 
lymph node in  vivo. The number of CD103+ and CD11b+ 
DCs, as well as uptake of OVA-AF647 by these DC subsets in 
Nlrp10−/− mice, was similar to that of WT mice, again indicating 
no defect in antigen uptake or DC migration in  vivo (Figure 
S5 in Supplementary Material). These findings are consistent 
with another study using a Nlrp10−/− mouse model with normal 
Dock8 expression (16).
Finally, we examined whether loss of NLRP10 impairs 
the ability of DCs to elicit CD4+ T-cell proliferation. WT and 
Nlrp10−/− DCs were primed with OVA and co-cultured with 
CellTrace Violet-labeled CD4+ OT-II T cells, and the dilution of 
the violet dye was measured after 3 days by flow cytometry. Here, 
Nlrp10−/− DCs elicited normal OVA-specific T-cell proliferation 
in vitro (Figure 2C). To assess CD4+ T-cell proliferation in vivo, 
WT and Nlrp10−/− mice underwent adoptive transfer with 
CellTrace Violet-labeled CD4+ OT-II T cells before immuniza-
tion with OVA plus alum. The division of OT-II T  cells in the 
inguinal lymph node was determined 5 days after immunization. 
Nlrp10 deficiency had no marked effect on the OVA-specific pro-
liferation of OT-II CD4+ T cells in the draining lymph nodes of 
Nlrp10−/− mice (Figure 2D). These results indicate that although 
NLRP10 in DCs is dispensable for responding CD4+ T cells to 
promote proliferation, it is absolutely required to elicit optimal 
IFNγ production.
Nlrp10−/− Dcs Produce less il-12 in 
response to cD40 ligation
We next aimed to delineate the mechanism(s) underlying 
diminished IFNγ production by CD4+ T cells upon Nlrp10−/− 
DC stimulation. To this aim, we assessed the production of 
IL-12 by DCs, which is necessary for optimal IFNγ production 
and induction of Th1  cell responses (23–25). OVA-primed, 
immature Nlrp10−/−, and WT DCs were incubated at dif-
ferent DC:T-cell ratios with OT-II CD4+ T  cells for 3  days 
before measuring the production of IL-12p40 in the culture 
supernatant. Robust IL-12p40 production was found in the 
OT-II T-cell and WT DC co-culture, whereas significantly less 
IL-12p40 was found in the OT-II T-cell and Nlrp10−/− DC co-
culture (Figure 3A). A similar defect in IL-12p40 production 
was observed in matured Nlrp10−/− DCs compared to WT DCs 
(Figure 3B).
IL-12p40 production can be elicited when DCs interact with 
T cells via CD40 cross-linking with the CD40L (26). Therefore, 
we investigated the response of DCs to CD40 ligation by co-
culturing them with L929 fibroblasts transfected with CD40L. 
WT DCs stimulated with CD40L-transfected fibroblasts 
produced high levels of IL-12p40, whereas their co-culture 
with mock-transfected fibroblasts had no effect (Figure  3C). 
Stimulation of Nlrp10−/− DCs with CD40L-transfected 
fibroblasts resulted in significantly less IL-12p40 production 
compared to WT DCs (Figure 3C). Similarly, upon ligation of 
CD40 with recombinant MegaCD40L (that simulates CD40L 
aggregates) Nlrp10−/− DCs produced significantly less IL-12p40 
compared to WT DCs (Figure  3D). Of note, stimulation of 
DCs in culture with antigen-activated T cells or CD40L failed 
to induce detectable levels of IL-12p70 (data not shown), as 
previously reported (27). These results indicate that NLRP10 is 
important for optimal IL-12p40 production after CD40 ligation 
on DCs.
nlrP10 Differentially Modulates il-12 
Production in response to Tlr 
stimulation
A microbial stimulus is required for effective production of 
active IL-12p70 heterodimers by DCs (27). This effect is mostly 
due to the rapid upregulation of CD40 on DCs by microbial 
stimuli, including TLR agonists (28). Microbial stimulation 
alone can also elicit IL-12p70 production by DCs (29). We thus 
investigated the ability of Nlrp10−/− DCs to produce IL-12p40 
and IL-12p70 in response to TLR stimulation. WT and Nlrp10−/− 
DCs were stimulated with Pam(3)CSK(4) (TLR1/2 agonist), LPS 
(TLR4 agonist), CpG DNA (TLR9 agonist), or PolyI:C (TLR3 
agonist) before assessment of IL-12p40 production. With the 
exception of PolyI:C, all tested TLR agonists elicited the produc-
tion of normal IL-12p40 levels by Nlrp10−/− DCs (Figures S6A,B 
in Supplementary Material). However, at the doses and times 
tested in our study, Nlrp10−/− DCs released significantly less 
IL-12p70 in response to CpG DNA compared to WT DCs, but no 
significant difference was observed between WT and Nlrp10−/− 
DCs in response to LPS (Figure 3E). IL-12p70 secretion by DCs 
in response to PolyI:C stimulation was undetectable (data not 
shown). Lower levels of IL-12p70 released by Nlrp10−/− DCs were 
also evident at different CpG DNA concentrations compared to 
WT DCs (Figure 3F). However, no significant difference in the 
levels of IL-12p40 was observed between WT and Nlrp10−/− DCs 
following stimulation with CpG DNA (Figure 3F; Figure S4 in 
Supplementary Material). We also examined the expression of 
Il12a and Il12b genes that encode IL-12p35 and IL-12p40, respec-
tively. While Il12b transcription was normal (similar to normal 
IL-12p40 protein), Il12a expression was significantly diminished 
in Nlrp10−/− DCs compared to WT DCs in response to CpG DNA 
stimulation (Figure 3G). Similar to IL-12, the production of IL-6 
and TNFα by CpG DNA or PolyI:C-stimulated Nlrp10−/− DCs 
was also diminished compared to WT DCs (Figure S6C in 
Supplementary Material). Taken together, these results indicate 
the critical involvement of NLRP10 in the differential control of 
TLR9-mediated cytokine production in response to CpG DNA 
stimulation by DCs.
Nlrp10−/− Dcs Display attenuated  
nF-κB signaling
Decreased cytokine production observed in Nlrp10−/− DCs may 
be due to reduced activation of inflammatory signaling path-
ways. To elucidate the molecular mechanism by which NLRP10 
regulates signal transduction, we carried out a high-throughput 
proteomic screen of potential NLRP10 targets using antibody 
arrays. NF-κB RelA and RelB, IκBα, and phosphorylated p38 
MAPK levels were markedly diminished in Nlrp10−/− DCs 
compared to WT DCs after CpG DNA stimulation (Figure 4A; 
Supplementary Table 1), indicating a role for NLRP10 in pro-
moting NF-κB activity in DCs.
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FigUre 3 | Continued
FigUre 3 | Continued  
 Nlrp10−/− DCs exhibit impaired IL-12 production after CD40 ligation or CpG DNA stimulation. (a,B) ELISA measurement of IL-12p40 levels in cell supernatants from 
OT-II CD4+ T cells co-cultured with immature (a) or matured (B) WT or Nlrp10−/− DCs loaded with ovalbumin (20 µg/ml) for 3 days. (c) WT and Nlrp10−/− DCs were 
incubated with L929 fibroblasts expressing or not expressing CD40 ligand (CD40L). Cell supernatants were collected after 3 days and the IL-12p40 levels were 
measured by ELISA. (D) ELISA measurement of IL-12p40 production by WT and Nlrp10−/− DCs stimulated by MegaCD40L for the indicated times. (e) WT and 
Nlrp10−/− DCs were left untreated or stimulated with either CpG DNA or LPS and the IL-12p70 levels in supernatants were then determined at the indicated times. 
(F) ELISA measurements of IL-12p70 and IL-12p40 production by WT and Nlrp10−/− DCs stimulated for 12 h with increasing concentrations of CpG DNA 
(0.001–10 µM). (g) Relative expression of Il12a and Il12b in WT and Nlrp10−/− DCs stimulated with CpG DNA (1 µM) for the indicated times and assessed by 
semi-quantitative RT-PCR. Data shown represent the mean ± SD and represent an experiment performed in triplicates and repeated with at least with three different 
DC preparations. *p < 0.05; **p < 0.01; ***p < 0.001. Abbreviations: DCs, dendritic cells; LPS, lipopolysaccharide; WT, wild-type.
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To validate the changes in NF-κB protein levels observed in 
our antibody array analysis, we measured the nuclear transloca-
tion of RelA (NF-κB p65) in WT and Nlrp10−/− DCs following 
CpG DNA stimulation. Consistently, RelA nuclear translocation 
was significantly decreased in Nlrp10−/− DCs compared to WT 
(Figures  4B,C). Reciprocally, the degradation of the NF-κB 
inhibitor IκBα following CpG DNA stimulation was increased 
in Nlrp10−/− DCs (Figure 4D). CpG DNA stimulation of TLR9 
can induce non-canonical activation of NF-κB. Consequently, 
we explored the role of NLRP10 in the nuclear translocation 
of RelB—the “non-canonical” NF-κB subunit—and found that 
its nuclear translocation was also diminished in Nlrp10−/− DCs 
(Figure 4C). Taken together, these data indicate a reduced activa-
tion of NF-κB pathway in Nlrp10−/− DCs following CpG DNA 
stimulation.
cpg Dna-induced Th1 response is 
abolished in Nlrp10−/− Mice
To confirm the impaired ability of Nlrp10−/− DCs to elicit 
cytokine production in  vivo, we exposed WT and Nlrp10−/− 
mice to CpG DNA or LPS via intraperitoneal (i.p.) injection, 
and measured the plasma levels of IL-12p40, IL-12p70, and 
IL-6 after 3 h. While CpG DNA-induced plasma IL-12p40 levels 
were comparable between Nlrp10−/− and WT mice, IL-12p70 
and IL-6 productions were significantly lower in Nlrp10−/− mice 
compared to WT (Figure  5A). By contrast, LPS treatment 
induced comparable IL-12p40, IL-12p70, and IL-6 production 
between WT and Nlrp10−/− mice (Figure S7 in Supplementary 
Material). In addition, CpG DNA-induced transcription of 
Il12a and Il12b in  vivo was significantly reduced in splenic 
DCs isolated from Nlrp10−/− mice compared to DCs from WT 
(Figure 5B).
Next, we aimed to determine whether reduced IL-12 produc-
tion by DCs from Nlrp10−/− mice upon CpG DNA exposure 
could promote defective IFNγ production by CD4+ T  cells in 
an antigen-specific setting. OT-II CD4+ T cells were adoptively 
transferred intravenously into WT and Nlrp10−/− mice prior to 
i.p. injection of OVA and CpG DNA. On day 3, CD4+ T cells were 
isolated and cultured with WT DCs that were loaded or not with 
OVA, and IFNγ production was analyzed (Figure  5C). OT-II 
CD4+ T cells from Nlrp10−/− mice produced less IFNγ compared 
to the similar cells from WT mice upon in vitro re-stimulation 
with OVA-loaded WT DCs (Figure 5D). Reduced IFNγ produc-
tion from co-cultures of OVA-loaded WT DCs with OT-II CD4+ 
T cells isolated from Nlrp10−/− mice was not due to a diminished 
proportion of OT-II CD4+ T cells within the total CD4+ T-cell 
population, as the percentage of OT-II CD4+ T cells in the spleens 
of WT and Nlrp10−/− mice were similar (data not shown). These 
data demonstrate that NLRP10 modulates the production of high 
levels of bioactive IL-12p70, upon exposure to CpG DNA in vivo, 
which leads to optimal IFNγ production by CD4+ T cells.
impaired il-12 Production renders 
Nlrp10−/− Mice susceptible to Mtb 
infection
IL-12 and IFNγ are essential for protective cell-mediated immu-
nity against various intracellular bacteria in mice (30) and in 
humans (31, 32). We thus sought to determine whether NLRP10 
is essential for immunity to Mtb–the etiological agent of tubercu-
losis. WT and Nlrp10−/− mice were infected with Mtb via aerosol 
inhalation, and the expression of cytokines, the phenotype of 
myeloid cells, and the bacterial load in the lung were investigated. 
Mtb-infected Nlrp10−/− mice had significantly lower levels of 
active IL-12p70 and IL-6 cytokines (Figure 6A) and expressed 
reduced Il12b and Ifnγ (Figure 6B), in the lung compared to WT 
mice. However, IP10 and MCP1 chemokine levels were equiva-
lent between WT and Nlrp10−/− mice (Figure 6A). In addition, 
Mtb-induced transcription of Il12a and Il12b in  vitro was sig-
nificantly reduced in BMDCs from Nlrp10−/− mice compared to 
BMDCs from WT mice (Figure 6C). Reduced IL-12 production 
by Nlrp10−/− BMDCs was not due to reduced Mtb infection, since 
bacterial counts were significantly increased in Nlrp10−/− BMDCs 
compared to WT BMDCs (Figure 6D). These data indicate that 
the increased survival of Mtb in Nlrp10−/− DCs is probably due 
to reduced killing effector functions in NLRP10-deficient DCs 
(Figure 6D).
To determine whether reduced DC-derived IL-12 results in 
decreased IFNγ production by CD4+ T cells, total lung leukocytes 
from Mtb-infected Nlrp10−/− and WT mice were re-stimulated 
ex vivo with Mtb-infected WT or Nlrp10−/− DCs (Figure  6E). 
CD4+ T  cells from Mtb-infected WT mice stimulated with 
Nlrp10−/− DCs produced lower levels of IFNγ compared to those 
stimulated with WT DCs (Figure 6E). In addition, CD4+ T cells 
from Mtb-infected Nlrp10−/− mice when re-stimulated with WT 
DCs restored the IFNγ production (Figure  6E). Collectively, 
these data indicate the attenuated capacity of Nlrp10−/− DCs to 
stimulate an Mtb-specific CD4+ T-cell response and that NLRP10 
deficiency in CD4+ T cells does not impact on the ability of these 
cells to produce IFNγ.
FigUre 4 |  Nlrp10−/− dendritic cells (DCs) elicit sub-optimal NF-κB activation following CpG DNA stimulation. (a) Heat map of log2 fold changes for Nlrp10−/− and 
WT DCs after CpG DNA treatment for 45 min (upregulated expression after treatment in red and downregulated expression in green). The proteins are clustered 
using hierarchical clustering with Euclidean distance. (B) Nuclear translocation of NF-κB RelA subunit in WT and Nlrp10−/− DCs following 30 min stimulation with 
CpG DNA. Confocal microscopic images show NF-κB RelA (green) and nuclei (blue) (magnification 40×; scale bars represent 50 µm). Percentage of DCs with 
predominantly nuclear NF-κB RelA in CpG DNA-treated WT and Nlrp10−/− DCs is shown on the right. Data represent the mean ± SD. (c,D) WT and Nlrp10−/− DCs 
were treated with CpG DNA for the indicated times. NF-κB RelA was examined in both the nuclear and cytosolic lysates, whereas NF-κB RelB and total IκBα were 
examined in the nuclear and cytosolic lysates, respectively. Lamin B and GAPDH were used as loading controls and as nuclear and cytosolic markers, respectively. 
Densitometry analysis of NF-κB RelA, RelB, and total IκBα. Data shown are representative of at least three independent experiments. **p < 0.01. Abbreviations: AU, 
arbitrary units; UT, untreated; WT, wild-type.
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FigUre 5 | Nlrp10−/− T cells show impaired IL-12 production and IFNγ release in vivo in response to TLR9 stimulation. (a) IL-12p40, IL-12p70 and IL-6 levels were 
measured in the sera of WT and Nlrp10−/− mice treated with CpG DNA for 3 h. Data are expressed as the mean ± SD. (B) Expression of Il12a and Il12b in splenic 
DCs isolated from WT and Nlrp10−/− mice 3 h after CpG DNA treatment. (c,D) Schematic of the adoptive transfer protocol. WT and Nlrp10−/− mice were adoptively 
transferred with CD4+ OT-II T cells and then exposed 24 h later to OVA plus CpG DNA via intraperitoneal injection. IFNγ production by OT-II T cells was evaluated by 
ELISA after in vitro re-stimulation for 3 days with WT DCs loaded or not with OVA. *p < 0.05; ***p < 0.001. Abbreviations: DCs, dendritic cells; OVA, ovalbumin; WT, 
wild-type.
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The impairment in cytokine production (Figure  6) in 
Nlrp10−/− mice was associated with a higher (~1 log10) bacillary 
burden in the lungs of Nlrp10−/− mice compared to WT mice 
(Figure 7A). This was accompanied by pronounced accumula-
tion of CD11b+Ly6G+ neutrophils (Figure 7B) and inflammatory 
monocytes (CD11b+Ly6C+; Figure  7C) in the lungs of Mtb-
infected Nlrp10−/− mice. Interestingly, a histologic examination 
of the lungs from WT and Nlrp10−/− mice 30 days post-infection 
did not reveal any striking differences in terms of the cellular 
diversity and composition of the lesions (Figure  7D). Lungs 
from WT and Nlrp10−/− mice displayed diffuse coalescent lesions, 
with numerous infiltrating macrophages and lymphocytes. 
However, higher numbers of intracellular acid-fast bacilli were 
observed in Nlrp10−/− mice compared to WT. Taken together, 
these observations indicate that NLRP10 mediates the ability of 
lung mononuclear phagocytes to produce IL-12, which drives a 
protective Th1-cell-mediated immune response that is critical for 
protection during Mtb infection.
DiscUssiOn
To date, the physiological role of NLRP10 in DCs and the 
immune response has been largely uncharacterized, mainly 
due to the lack of a suitable animal model. Here, we generated 
a new Nlrp10−/− mouse to demonstrate in vitro and in vivo that 
NLRP10 has an important role in inducing IL-12 production by 
DCs. Sub-optimal IL-12 production by Nlrp10−/− DCs resulted 
in impaired IFNγ production by antigen-specific CD4+ T cells, 
which possibly leads to increased susceptibility to Mtb infection. 
Our data emphasize the protective nature of NLRP10 against 
FigUre 6 |  Nlrp10−/− DCs have attenuated capacity to stimulate a Mtb-specific CD4+ T-cell response. (a) IL-12p70, IL-6, IP10 and MCP1 levels in lung homogenates 
of WT and Nlrp10−/− mice at different times after Mtb infection, as determined by ELISA. (B) Il12b and Ifng mRNA expressions in lung leukocytes isolated from 
Mtb-infected WT and Nlrp10−/− mice, as determined by semi-quantitative RT-PCR. (c) Il12a and Il12b mRNA expressions in bone marrow-derived dendritic cells 
(BMDCs) infected with Mtb, as assessed by semi-quantitative RT-PCR. (D) CFUs measured in Nlrp10−/− and WT BM-derived DCs 24 and 48 h after Mtb infection.  
(e) Lung leukocytes collected from Nlrp10−/− and WT mice 35 days post-Mtb infection were re-stimulated in vitro with Mtb-infected WT or Nlrp10−/− DCs for 16 h.  
The percentage of IFNγ-producing CD4+CD137+ T cells was assessed by flow cytometry. Data represent the mean ± SE. *p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: DCs, dendritic cells; FACS, florescence-activated cell sorting; Mtb, Mycobacterium tuberculosis; WT, wild-type; CFUs, colony-forming units.
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FigUre 7 |  Nlrp10 deficiency is associated with increased susceptibility to Mtb infection. (a) Bacterial load was measured in lung from Nlrp10−/− and WT mice 
35 days after Mtb infection. Percentage of CD11b+Ly6G+ neutrophils (B) and CD11b+Ly6C+ inflammatory monocytes (c) was determined by flow cytometry in lung 
cellular suspensions obtained from Nlrp10−/− and WT mice 7 days after Mtb infection. Frequency and absolute cell numbers are represented as mean ± SE.  
(D) Representative lung sections of Nlrp10−/− and WT mice infected with Mtb for 30 days. Magnifications 4×, 40× (H&E), and 80× (AF). *p < 0.05; **p < 0.01; 
***p < 0.001. Abbreviations: CFUs, colony-forming units; WT, wild-type.
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microbial pathogens, thus adding NLRP10 to the group of NLR 
family members such as NOD1, NOD2, NLRC4, NLRP3, and 
NLRP12 that initiate pro-inflammatory signaling to mediate host 
resistance toward bacterial infections (6, 33–35).
IL-12-induced IFNγ is primarily produced by T cells and has 
an essential role in the host defense against various bacterial 
pathogens, including Mtb. Mice deficient in Il12, Il12R, genes 
regulating IFNγ expression (i.e., Tbet and Stat1) or IFNγ itself are 
extremely susceptible to Mtb infection (30, 36, 37). Furthermore, 
people with inborn mutations in genes within the IL-12/
IFNγ axis are highly susceptible to normally avirulent, non-
tuberculous mycobacterial infections (38). Here, we found that 
Mtb-infected Nlrp10−/− mice had attenuated IL-12p70 produc-
tion, which is due in part to the impaired ability of Nlrp10−/−DCs 
to synthesize Il12a and Il12b. Reduced IL-12p70 release resulted 
in diminished production of IFNγ by CD4+ T cells. The results 
of our criss-cross experiment demonstrated that NLRP10 has 
an important role in DCs, but not T cells, during Mtb infection, 
as the percentage of IFNγ-producing CD4+ T cells was restored 
when CD4+ T cells from Nlrp10−/− mice were re-stimulated ex 
vivo by Mtb-infected WT DCs, but not by DCs obtained from 
Nlrp10−/− mice. Moreover, NLRP10 deficiency resulted in higher 
bacterial survival in DCs in vitro and in the lungs in vivo com-
pared to WT and was accompanied by enhanced infiltration of 
neutrophils and monocytes in the lungs.
Although the initial recruitment of neutrophils and inflam-
matory monocytes during infection provides the first line of 
defense against Mtb infection (39), this recruitment is also 
associated with enhanced mycobacterial load and disease 
exacerbation (21, 40). In addition, IFNγ directly inhibits 
pathogenic neutrophil accumulation in the infected lung and 
impairs neutrophil survival (41). Thus, our data suggest that 
low IFNγ production in Nlrp10−/− mice could be responsible 
for the enhanced infiltration of neutrophils and myeloid cells 
seen in our experiments (42). Likewise, a significant increase 
in infiltrating neutrophils was also evident in lesioned ears of 
Nlrp10−/− mice during the cutaneous inflammatory response 
induced by L. major infection (13), indicating that NLRP10 may 
regulate a general innate immune response against intracellular 
pathogens.
Dendritic cells produce IL-12p70 following exposure to 
PAMPs. No previous physiological functions in inflammation 
or innate immune defenses have been established for NLRP10. 
Here, we elucidated NLRP10 as a specific positive regulator of 
NF-κB activation in DCs upon stimulation of TLR9 by CpG DNA, 
thereby supporting optimal IL-12p70 and other cytokines. We 
found that requirement of NLRP10 for IL-12p40 and IL-12p35 
synthesis in  vitro varied depending on the stimulus used. 
NLRP10 is required for IL-12p40 release from CD40-stimulated 
DCs and T-cell-mediated stimulation, but it is dispensable to 
CpG-stimulated and LPS-stimulated DCs. Moreover, IL-12p40 
production by PolyI:C-stimulated DCs was also dependent on 
NLRP10; CpG-induced IL-12p35 synthesis by DCs involves 
NLRP10. Interestingly, production of the IL-12p40/IL-12p35 
heterodimer was undetectable in DC cultures upon CD40 stim-
ulation, suggesting that the active IL-12p70 cytokine requires 
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a microbial priming signal, as previously described (28). We 
found that in  vivo, NLRP10 is required by DCs for efficient 
release of IL-12p40 and IL-12p35 following Mtb infection and 
CpG, but not LPS, administration. The differential requirement 
of NLRP10 in DCs for IL-12 production could be explained by 
the fact that it may be required for intracellular TLR-mediated 
signaling rather than as a trigger by extracellular TLRs. Another 
possible explanation is that the downstream signaling of TLR4 
is dependent on both MyD88 and TRIF (1), which promotes 
NF-κB and IRF activation, respectively (43). By contrast, TLR9 
interacts with MyD88 (its only adaptor molecule) to activate 
NF-κB signaling, whereas TLR3 engagement with PolyI:C 
induces the TRIF pathway. Thus, it is possible that the engage-
ment of both the MyD88 and TRIF pathways in LPS-stimulated 
DCs may bypass the requirement of NLRP10 for NF-κB activa-
tion. Indeed, human and mouse DCs produce maximal levels of 
IL-12p70 when IL-12p40 and IL-12p35 are induced by ligands 
that engage both MyD88 and TRIF signaling (44). Moreover, 
the differential requirement of NLRP10 for cytokine produc-
tion may be explained by considering the differential ability of 
certain stimuli to engage different signaling adaptors that lead to 
the canonical and/or non-canonical NF-κB pathways. A natural 
direction for future investigations will be to ascertain the role 
of NLRP10 in the activation of the NF-κB pathway primarily 
triggered by microbial signals.
Other NLRs besides NLRP10 have been implicated in NF-κB 
signaling. Stimulation of NOD1 and NOD2 by peptidoglycan-
derived molecules (iE-DAP dipeptide and muramyl dipeptide, 
respectively) results in the activation of NF-κB and p38 MAPK 
via the receptor-interacting kinase RIP2, which in turn leads to 
NF-κB-mediated transcription of numerous pro-inflammatory 
genes (2). One study showed that ectopically expressed human 
NLRP10 colocalizes with NOD1 in HeLa cells upon infection 
with Shigella flexneri (12). Oligomerization of NACHT and 
PYD domains and ATPase activity of NLRP10 are required to 
stabilize this interaction (12). NLRP10 can also interact with 
other components of the NOD1 signaling cascade, including 
RIP2, TAK1, and the NF-κB activating protein NEMO/IKKγ 
(12). Abrogation of NLRP10 expression in epithelial cells 
reduced IL-8 and IL-6 release due to diminished activation of 
p38 MAPK, as well as NF-κB–RelA/p65 activity upon HeLa 
cell infection with S. flexneri (12). As these studies have been 
conducted using non-immune cell lines, new approaches that 
are designed to analyze the contribution of NLRP10 in the 
signaling pathways involved in the innate and adaptive immune 
responses are warranted.
In conclusion, our study has identified an unprecedented and 
biologically relevant in  vivo role for NLRP10 as a regulator of 
IL-12 release by DCs to promote IFNγ production by Th1 cells. 
Improved understanding of the immune mechanisms regulated 
by this NLR that is still largely uncharacterized will advance our 
current knowledge in pathogen recognition and regulation of 
innate and adaptive immune responses.
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